Please reload

Recent Posts

A/Prof. Colin Chan talks about Covid-19 and importance of ongoing eye care in Mivision

May 10, 2020

Please reload

Featured Posts

FDA approval for Crosslinking for keratoconus

February 28, 2018

 I was invited by Eyeworld Asia-Pacific to comment on the various opinions of surgeons on crosslinking for keratoconus and its recent FDA approval.  Keratoconus is a progressive degenerative condition of the cornea which affects mainly teenagers and young adults. It is the most common reason for a corneal transplant in Australia and New Zealand. Crosslinking is a treatment that stops the deterioration and has been shown to reduce the number of young people needing a transplant for this sight threatening condition. I have been performing crosslinking since 2006.


Share on Facebook
Share on Twitter
Please reload

Follow Us
Search By Tags
Please reload

  • Facebook Basic Square
  • Instagram Social Icon